Literature DB >> 25830897

Influence of sample return time and ambient temperature on the performance of an immunochemical faecal occult blood test with a new buffer for colorectal cancer screening.

Vincent Dancourt1, Samia Hamza, Sylvain Manfredi, Antoine Drouillard, Jeanne-Marie Bidan, Jean Faivre, Come Lepage.   

Abstract

The haemoglobin concentration measured by faecal immunochemical tests (FIT) may be decreased in cases of delayed sample return or high temperature. It is an issue of great importance. The aim of this study was to investigate the effects of sample return time and of season on the performance of an FIT (FOB-Gold) with a new buffer. The study included 20 371 participants involved in the French organized colorectal cancer (CRC) screening programme. The probability of a positive screening test, detection rates and positive predictive values for CRC and advanced adenoma were analysed according to sample return time and season of screening. A sample of positive FIT was stored for 7 days in an incubator at 20°C or 30°C. The positivity rate was 4.1% for a sample return time of up to 3 days, 4.1% for 4-5 days and 4.6% for 6-7 days (P=0.25). In multivariate analysis, there was no association between positivity rates, detection rates and positive predictive values for CRC and advanced adenoma and the sample return time or the season of screening. At a constant temperature of 20°C, there was a decrease in the haemoglobin concentration of 5.1% after 7 days. The decrease reached 20.5% at a temperature of 30°C. It was only 4.5% during the first 4 days of storage in the incubator. With the new buffer, delay in sample return or season did not affect the clinical outcome. When temperatures reach 30°C, the faecal sample must be returned promptly.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 25830897     DOI: 10.1097/CEJ.0000000000000153

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  9 in total

1.  Low Literacy Level Instructions and Reminder Calls Improve Patient Handling of Fecal Immunochemical Test Samples.

Authors:  Andrew Wang; Carly Rachocki; Jean A Shapiro; Rachel B Issaka; Ma Somsouk
Journal:  Clin Gastroenterol Hepatol       Date:  2018-11-29       Impact factor: 11.382

2.  Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature.

Authors:  Chyke A Doubeni; Christopher D Jensen; Stacey A Fedewa; Virginia P Quinn; Ann G Zauber; Joanne E Schottinger; Douglas A Corley; Theodore R Levin
Journal:  J Am Board Fam Med       Date:  2016-11-12       Impact factor: 2.657

3.  Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.

Authors:  Clasine M de Klerk; Lisanne M Vendrig; Patrick M Bossuyt; Evelien Dekker
Journal:  Am J Gastroenterol       Date:  2018-08-29       Impact factor: 10.864

Review 4.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas J Robertson; Jeffrey K Lee; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

5.  Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea.

Authors:  Jae Myung Cha; Mina Suh; Min Seob Kwak; Na Young Sung; Kui Son Choi; Boyoung Park; Jae Kwan Jun; Sang-Hyun Hwang; Do-Hoon Lee; Byung Chang Kim; You Kyoung Lee; Dong Soo Han
Journal:  Am J Gastroenterol       Date:  2018-03-06       Impact factor: 10.864

6.  A Correctional-Public Health Collaboration for Colorectal Cancer Screening in a State Prison System.

Authors:  Dora M Dumont; Deborah Davis; Radha Sadacharan; Eric Lamy; Jennifer G Clarke
Journal:  Public Health Rep       Date:  2021-02-09       Impact factor: 3.117

7.  Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.

Authors:  Samir Gupta; Gloria D Coronado; Keith Argenbright; Alison T Brenner; Sheila F Castañeda; Jason A Dominitz; Beverly Green; Rachel B Issaka; Theodore R Levin; Daniel S Reuland; Lisa C Richardson; Douglas J Robertson; Amit G Singal; Michael Pignone
Journal:  CA Cancer J Clin       Date:  2020-06-25       Impact factor: 286.130

8.  Impact of temperature and humidity on performance of the fecal immunochemical test for advanced colorectal neoplasia.

Authors:  Chan Hyuk Park; Yoon Suk Jung; Nam Hee Kim; Mi Yeon Lee; Jung Ho Park; Dong Il Park; Chong Il Sohn
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

9.  Diagnostic Performance of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program According to Ambient Temperature and Humidity.

Authors:  Gemma Ibáñez-Sanz; Núria Milà; Núria Vives; Carmen Vidal; Gemma Binefa; Judith Rocamora; Carmen Atencia; Víctor Moreno; Rebeca Sanz-Pamplona; Montse Garcia
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.